TY - JOUR
T1 - Iron induces protection and necrosis in cultured cardiomyocytes
T2 - Role of reactive oxygen species and nitric oxide
AU - Munoz, Juan Pablo
AU - Chiong, Mario
AU - García, Lorena
AU - Troncoso, Rodrigo
AU - Toro, Barbra
AU - Pedrozo, Zully
AU - Diaz-Elizondo, Jessica
AU - Salas, Daniela
AU - Parra, Valentina
AU - Núñez, Marco T.
AU - Hidalgo, Cecilia
AU - Lavandero, Sergio
N1 - Funding Information:
This work was supported by the Comisión Nacional de Ciencia y Tecnología (CONICYT, Chile) Program Fondo de Areas Prioritarias (FONDAP) (Grant 15010006 to S.L. and C.H.), Proyecto Postdoctorado (3060082 to J.P.M.), and Iniciativa Cientifica Milenio (P05001-F to M.T.N.). R.T., Z.P., B.T., J.D.E., and V.P. hold Ph.D. fellowships from CONICYT, Chile. We thank Fidel Albornoz and Ruth Marquez for their excellent technical assistance.
PY - 2010/2/15
Y1 - 2010/2/15
N2 - We investigate here the role of reactive oxygen species and nitric oxide in iron-induced cardiomyocyte hypertrophy or cell death. Cultured rat cardiomyocytes incubated with 20 μM iron (added as FeCl 3-Na nitrilotriacetate, Fe-NTA) displayed hypertrophy features that included increased protein synthesis and cell size, plus realignment of F-actin filaments along with sarcomeres and activation of the atrial natriuretic factor gene promoter. Incubation with higher Fe-NTA concentrations (100 μM) produced cardiomyocyte death by necrosis. Incubation for 24 h with Fe-NTA (20-40 μM) or the nitric oxide donor Δ-nonoate increased iNOS mRNA but decreased iNOS protein levels; under these conditions, iron stimulated the activity and the dimerization of iNOS. Fe-NTA (20 μM) promoted short- and long-term generation of reactive oxygen species, whereas preincubation with l-arginine suppressed this response. Preincubation with 20 μM Fe-NTA also attenuated the necrotic cell death triggered by 100 μM Fe-NTA, suggesting that these preincubation conditions have cardioprotective effects. Inhibition of iNOS activity with 1400 W enhanced iron-induced ROS generation and prevented both iron-dependent cardiomyocyte hypertrophy and cardioprotection. In conclusion, we propose that Fe-NTA (20 μM) stimulates iNOS activity and that the enhanced NO production, by promoting hypertrophy and enhancing survival mechanisms through ROS reduction, is beneficial to cardiomyocytes. At higher concentrations, however, iron triggers cardiomyocyte death by necrosis.
AB - We investigate here the role of reactive oxygen species and nitric oxide in iron-induced cardiomyocyte hypertrophy or cell death. Cultured rat cardiomyocytes incubated with 20 μM iron (added as FeCl 3-Na nitrilotriacetate, Fe-NTA) displayed hypertrophy features that included increased protein synthesis and cell size, plus realignment of F-actin filaments along with sarcomeres and activation of the atrial natriuretic factor gene promoter. Incubation with higher Fe-NTA concentrations (100 μM) produced cardiomyocyte death by necrosis. Incubation for 24 h with Fe-NTA (20-40 μM) or the nitric oxide donor Δ-nonoate increased iNOS mRNA but decreased iNOS protein levels; under these conditions, iron stimulated the activity and the dimerization of iNOS. Fe-NTA (20 μM) promoted short- and long-term generation of reactive oxygen species, whereas preincubation with l-arginine suppressed this response. Preincubation with 20 μM Fe-NTA also attenuated the necrotic cell death triggered by 100 μM Fe-NTA, suggesting that these preincubation conditions have cardioprotective effects. Inhibition of iNOS activity with 1400 W enhanced iron-induced ROS generation and prevented both iron-dependent cardiomyocyte hypertrophy and cardioprotection. In conclusion, we propose that Fe-NTA (20 μM) stimulates iNOS activity and that the enhanced NO production, by promoting hypertrophy and enhancing survival mechanisms through ROS reduction, is beneficial to cardiomyocytes. At higher concentrations, however, iron triggers cardiomyocyte death by necrosis.
UR - http://www.scopus.com/inward/record.url?scp=74149084445&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=74149084445&partnerID=8YFLogxK
U2 - 10.1016/j.freeradbiomed.2009.11.017
DO - 10.1016/j.freeradbiomed.2009.11.017
M3 - Article
C2 - 19969068
AN - SCOPUS:74149084445
SN - 0891-5849
VL - 48
SP - 526
EP - 534
JO - Free Radical Biology and Medicine
JF - Free Radical Biology and Medicine
IS - 4
ER -